These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence? Owen DR; MacAllister R; Sofat R Clin Pharmacol Ther; 2015 Aug; 98(2):119-21. PubMed ID: 25786394 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study. Civera J; de la Espriella R; Heredia R; Miñana G; Santas E; Conesa A; Mollar A; Sastre C; Martínez A; Villaescusa A; Núñez J J Cardiovasc Transl Res; 2022 Jun; 15(3):644-652. PubMed ID: 34642870 [TBL] [Abstract][Full Text] [Related]
5. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM; Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981 [TBL] [Abstract][Full Text] [Related]
6. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis. Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531 [TBL] [Abstract][Full Text] [Related]
7. [A better diuretic for patients with heart failure. Better control of potassium loss]. MMW Fortschr Med; 2002 Aug; 144(31-32):56. PubMed ID: 12422742 [No Abstract] [Full Text] [Related]
8. Subcutaneous furosemide in patients with refractory heart failure. Lozano Bahamonde A; Escolar Pérez V; Laskibar Asua A; Rodríguez Rodríguez M; Murga Eizagaechevarria N BMJ Support Palliat Care; 2018 Sep; 8(3):354-355. PubMed ID: 29903849 [No Abstract] [Full Text] [Related]
9. Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function. van Kraaij DJ; Jansen RW; Bouwels LH; Hoefnagels WH Arch Intern Med; 1999 Jul; 159(14):1599-605. PubMed ID: 10421283 [TBL] [Abstract][Full Text] [Related]
10. Etiology of discharge hyponatremia in decompensated heart failure and normal admission Na Omar HR; Guglin M Eur J Intern Med; 2018 Feb; 48():e15-e17. PubMed ID: 29276159 [No Abstract] [Full Text] [Related]
11. Can we improve the treatment of congestion in heart failure? Metra M; Bugatti S; Bettari L; Carubelli V; Danesi R; Lazzarini V; Lombardi C; Cas LD Expert Opin Pharmacother; 2011 Jun; 12(9):1369-79. PubMed ID: 21342081 [TBL] [Abstract][Full Text] [Related]
12. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486 [TBL] [Abstract][Full Text] [Related]
13. [Acute tubular necrosis caused by combination of diuretics in the treatment of several heart failure. A call to attention]. de Luis DA; Liaño F; Pascual J; Ortuño J Rev Clin Esp; 1997 Aug; 197(8):592-3. PubMed ID: 9312802 [No Abstract] [Full Text] [Related]
14. Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure. Gilotra NA; Princewill O; Marino B; Okwuosa IS; Chasler J; Almansa J; Cummings A; Rhodes P; Chambers J; Cuomo K; Russell SD JACC Heart Fail; 2018 Jan; 6(1):65-70. PubMed ID: 29226816 [TBL] [Abstract][Full Text] [Related]
15. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Sancho-Zamora MA Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):241-2. PubMed ID: 24774406 [No Abstract] [Full Text] [Related]
16. Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. Mouallem M; Brif I; Mayan H; Farfel Z Int J Cardiol; 1995 Jun; 50(2):89-94. PubMed ID: 7591335 [TBL] [Abstract][Full Text] [Related]
17. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response. Zatarain-Nicolás E; de la Fuente-Galán L; San Román-Calvar JA Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):242. PubMed ID: 24774407 [No Abstract] [Full Text] [Related]
18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
19. Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study. Kapelios CJ; Kaldara E; Ntalianis A; Nana E; Pantsios C; Repasos E; Margari Z; Sousonis V; Malliaras K; Nanas JN Int J Cardiol; 2014 Dec; 177(2):690-2. PubMed ID: 25304067 [No Abstract] [Full Text] [Related]
20. Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience. Zatarain-Nicolás E; López-Díaz J; de la Fuente-Galán L; García-Pardo H; Recio-Platero A; San Román-Calvar JA Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):1002-4. PubMed ID: 24774118 [No Abstract] [Full Text] [Related] [Next] [New Search]